United States Sees Continued Drop in New COVID-19 Cases
Current decline in infections most pronounced in the Midwest
J&J Submits EUA Request for COVID-19 Vaccine
FDA committee will hold public meeting to discuss the EUA request on Feb. 26
High Efficacy Reported for Sputnik V COVID-19 Vaccine
Interim analysis of data from phase 3 trial shows 91.6 percent efficacy at 21 days after the first dose of the vaccine
Companies Developing Vaccines Against New Coronavirus Variants
GlaxoSmithKline and CureVac to create vaccines that use messenger RNA to combat the virus
Racial Disparities Seen in Excess Mortality Early in Pandemic
Adjusted excess all-cause mortality was 6.8 per 10,000 for Blacks and 1.5 per 10,000 for Whites, with considerable variation across states
First Federal COVID-19 Vaccination Sites to Open in California
One center will be housed in the Oakland Coliseum, another on the campus of California State University, Los Angeles
McKinsey to Pay $573 Million Over Role in Opioid Crisis
Most of the money would be distributed to states in less than a year and be used to combat the opioid overdose epidemic
Oncology Clinical Trials Decline During Pandemic
Decline in trial launches could have long-term negative impact, authors say
Biden Administration to Start Shipping COVID-19 Vaccines Directly to U.S. Pharmacies
In addition, starting this week, states are receiving 5 percent more vaccine doses
Opioid-Minimizing Pain Management Feasible for Trauma Patients
MAST MMPR regimen includes oral acetaminophen, naproxen, gabapentin, lidocaine patches, and as-needed opioids
